A B S T R A C T Circulating DNA has been associated with several human disorders, including the nephritis of systemic lupus erythematosus (SLE), in which it is thought to play an etiological role. However, it remains unclear whether its appearance in the circulation is truly pathological. Several reports, each generally based on a single assay method, have disagreed as to whether DNA may circulate in normals. Some, but not all, of this disagreement may be explained by the recently described appearance of DNA in serum, but not plasma, apparently as the result of release from leukocytes in vitro.
INTRODUCTION
Circulating DNA has assumed clinical importance because of its association with several human disorders (1, 2) and in particular with the immune complex nephritis accompanying systemic lupus erythematosus (SLE)' in which, in combination with anti-DNA antibody, it appears to play an etiologic role (1). In addition, recent reports have suggested that anti-DNA antibody might be found not only in SLE, but also in patients with other collagen diseases (3) , as well as in normals (4) . Hence, it seems imperative to clearly establish whether free DNA may be found in the normal circulation, or whether it appears only in conjunction with pathological states. Surprisingly, the literature is conflicting on this point, the majority of reports claiming to have identified such DNA in normals (5) (6) (7) (8) , but with a number of dissents (1, 2, 9). The recently described release of DNA into serum during clotting may help in part to clarify the problem (2) . However, even studies confined to normal plasma have been in disagreement, with mean DNA concentrations reported from as low as 0 (2) to as high as 35.2 iag/ml (5) . Since Diphenylamine assay (DPA). The procedure of Giles and Myers (11) was modified to allow measurement of the material rendered acid-soluble by treatment with DNAase. Duplicate 1-ml samples of plasma were incubated for 15 min at 37°C in the presence of 0.02 M MgC12 after the addition of either DNAase (200 ,ug/ml) or an equal volume of buffer alone. They were then made 0.5 M in NaClO4 and the same amount of DNAase or buffer was again added, followed by incubation for an additional 30 min. Each sample was then precipitated at 4°C with 10% trichloracetic acid (TCA), washed, redissolved in 6 M NaOH at 200 C, neutralized with HC1, and reprecipitated with TCA at 4°C. Each precipitate was extracted with 1 ml of 10% perchloric acid (PCA) at 70°C for 20 min. A 0.5-ml aliquot of this extract was then used for the deoxyribose assay, as described previously (11) . The optical density at 595 nm was corrected for turbidity by subtracting the reading at 700 nm. Two sets of standards were routinely included, one in 10% PCA and the other in normal plasma treated as above. The standard curve for plasma DNA was linear below 200 ,ug/ml. The plasma DNAase treatment was adequate to solubilize more than 90% of the DNA present in crude lysates of both Micrococcus lysodeikticus and of human leukocytes as determined by the DPA and hybridization assays (vide infra), respectively.
Ethidium bromide (EB) assay. A method employing enhancement of fluorescence of EB when bound to native (n)DNA was followed as described (6) differences between the DNAase-treated and untreated paired samples significant. If, in the EB assay, the DNAase-treated blank is replaced by one consisting of plasma lacking EB and the resulting difference in fluorescence converted to "apparent DNA" by reference to a standard curve, a mean of 17.5 gg/ml is found. This compares with 13.9 /Lg/ml reported by Kamm and Smith (6) using this type of blank and presumably results from enhancement of the fluorescence of EB by non-DNAase-and non-RNAase sensitive materials. The fluorescence of the same amount of EB added to buffer alone was found to account for less than 10% of the difference.
In the hybridization assay, negative controls containing carrier DNA added directly to the assay mixture without having been re-isolated from plasma gave results indistinguishable from those derived from the DNAase-treated plasma samples. This result further confirms the efficacy of the DNAase treatment, as it is inconsistent with the presence of significant amounts of DNAase-resistant DNA in plasma in a form detectable by hybridization.
Only one of the 24 normal plasma samples demonstrated a faint line of precipitation by CIE. Pretreatment of the samples with pronase, 1 mg/ml at 60'C for 1 h, did not result in detection of DNA To confirm these results, nine sera, positive by CIE, were selected for examination by hybridization. All nine demonstrated greater hybridization than did their paired DNAase-treated controls, a result highly significant by chi square analysis with the sign test (P < 0.004) (12) .
(Similar application of this test to the data on normal plasma showed no significant differences resulting from DNAase treatment in any of the assays). The DNAaseresistant hybridization had a mean+SEM of 14.1±9.3 cpm and a range of 1.1-74.0 cpm. Thus the wide variability in the previously noted amount of serum DNA was also confirmed by hybridization (coefficient of variation = 66%). DISCUSSION The results obtained in this study with the EB assay, as well as previously published data on the DPA method (9) , suggest that reports of finding DNA in plasma, at least by these methods, resulted from measurement of interfering substances rather than of true DNA. Except for the use of DNAase-treated, paired controls, the validity of which was demonstrated above, the four assays used in the present study are based on independent principles and therefore complement each other. Thus, although the possibility cannot be ruled out that DNA is present in normal plasma in an unusual form that eludes detection by all four methods, this appears un- likely. Rather, in accord with several previous studies, as noted above, their agreement in not finding DNA would seem to imply its absence as defined by the limits of sensitivity noted (0.05 /g/ml for CIE). Thus, it can be concluded that the presence of free nDNA in amounts greater than this (and of ssDNA in amounts greater than 0.1 /hg/ml, as detectable by hybridization) in plasma is pathological.
The previously reported erratic occurrance of DNA in serum was confirmed in this study (2) . Although of little relevance to previous work demonstrating circulating DNA with comparatively insensitive techniques such as Ouchterlony analysis (1, 15), this apparent artifact may lead to confusion when more sensitive assays are utilized. Thus studies dependent on the identification of small concentrations of DNA, for example, as in the reported demonstration in SLE of DNA-anti-DNA immune complexes (16) , would more securely reflect the in vivo state if performed on atraumatically collected plasma than on serum. Similarly, measurements of anti-nDNA antibody by the sensitive Farr technique (17) might potentially be interfered with unpredictably by this phenomenon and might more reliably be performed on plasma.
